Related Experiment Video
Updated: Apr 14, 2026
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
1.3K
PVT1: a rising star among oncogenic long noncoding RNAs
Teresa Colombo1, Lorenzo Farina2, Giuseppe Macino3
1Institute for Computing Applications "Mauro Picone", National Research Council, Via dei Taurini 19, 00185 Rome, Italy.
Biomed Research International
|April 18, 2015
Summary
Long noncoding RNAs (lncRNAs) like PVT1 are crucial for cell regulation. Research is uncovering PVT1's role in cancer, particularly its interaction with the MYC oncogene, though its mechanisms require further study.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Short and long noncoding RNAs (lncRNAs) are key regulators of cellular processes.
- Functional characterization of lncRNAs, especially long noncoding RNAs, is still developing.
- The lncRNA PVT1, located in the 8q24 cancer risk region, has been understudied due to a focus on protein-coding genes and the MYC oncogene.
Purpose of the Study:
- To highlight the emerging role of the long noncoding RNA PVT1 in cellular regulation and cancer.
- To discuss recent findings on PVT1's potential mechanisms of action, including competing endogenous RNA activity and regulation of oncogene protein stability.
- To identify knowledge gaps regarding the precise molecular functions of PVT1 in cancer.
Main Methods:
- Literature review of recent studies on PVT1 and noncoding RNAs.
- Analysis of genetic data related to the 8q24 cancer risk region.
- Functional studies investigating PVT1 interactions with MYC and other oncogenes (implied).
Main Results:
- PVT1 is implicated in regulating cell growth, differentiation, and function.
- Emerging evidence suggests PVT1 acts as a competing endogenous RNA.
- PVT1 influences the stability of key oncogenes, notably MYC.
Conclusions:
- PVT1 plays a significant role in cancer, warranting further investigation.
- Understanding PVT1's molecular mechanisms is crucial for advancing cancer research.
- Despite progress, many questions remain about PVT1's precise functions in oncogenesis.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
10.2K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
02:39lncRNA - Long Non-coding RNAs
3.9K
3.9K
03:18Non-LTR Retrotransposons
14.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.1K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.7K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.1K
6.1K
01:33Cancer-Critical Genes I: Proto-oncogenes
12.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.2K